1. Home
  2. MLKN vs NNNN Comparison

MLKN vs NNNN Comparison

Compare MLKN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$14.41

Market Cap

1.3B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$26.03

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MLKN
NNNN
Founded
1905
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
MLKN
NNNN
Price
$14.41
$26.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
925.7K
21.5K
Earning Date
03-25-2026
04-28-2026
Dividend Yield
5.17%
N/A
EPS Growth
N/A
N/A
EPS
0.98
N/A
Revenue
$3,669,900,000.00
N/A
Revenue This Year
$6.90
N/A
Revenue Next Year
$4.79
N/A
P/E Ratio
$14.81
$446.57
Revenue Growth
1.14
N/A
52 Week Low
$13.77
$5.91
52 Week High
$23.18
$55.65

Technical Indicators

Market Signals
Indicator
MLKN
NNNN
Relative Strength Index (RSI) 24.91 56.06
Support Level $13.77 $19.53
Resistance Level $19.86 $30.70
Average True Range (ATR) 0.74 2.10
MACD -0.39 0.54
Stochastic Oscillator 10.25 70.81

Price Performance

Historical Comparison
MLKN
NNNN

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: